Related Experiment Video
Updated: Jul 21, 2026

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
The risk of gastrointestinal carcinoma in familial juvenile polyposis
J R Howe1, F A Mitros, R W Summers
1Department of Surgery, University of Iowa College of Medicine, Iowa City 52242-1086, USA.
Insights
Familial juvenile polyposis (JP) significantly increases gastrointestinal cancer risk, exceeding 50% in affected individuals. Early endoscopic screening and genetic testing are crucial for managing this hereditary condition.
Area of Science:
- Gastroenterology
- Medical Genetics
- Oncology
Background:
- Familial juvenile polyposis (JP) is an autosomal dominant disorder characterized by gastrointestinal (GI) juvenile polyps.
- JP confers a predisposition to GI cancers, but the precise cancer risk and age of onset are not well-defined.
- This study investigates GI polyposis and cancer prevalence in a large JP kindred.
Purpose of the Study:
- To determine the prevalence and age at diagnosis of GI polyposis and cancer in a large familial juvenile polyposis kindred.
- To better define the cancer risk associated with JP.
Main Methods:
- Review of medical records, patient interviews, and history taking.
- Pathology report and slide review by expert pathologists.
- Creation of a database for clinical and pathologic factor analysis.
Main Results:
- The kindred comprises 117 members; 29 (25%) were affected with GI polyps or cancer.
- Gastrointestinal cancer developed in 16 of 29 (55%) affected individuals.
- Colon cancer occurred in 11 (38%) and upper GI cancers in 6 (21%) affected patients.
Conclusions:
- The risk of gastrointestinal malignancy in this JP kindred exceeds 50%.
- Frequent endoscopic screening is recommended for affected and at-risk family members.
- Presymptomatic genetic testing will aid in identifying gene carriers for facilitated screening.
Background:
Familial juvenile polyposis (JP) is an autosomal dominant condition in which affected individuals develop upper or lower gastrointestinal (GI) juvenile polyps, or both, and have a predisposition to cancer of the gastrointestinal tract. The risk of GI cancer has not been well defined because of the small number of these families and the lack of follow-up. The objective of this study was to determine the prevalence and age at diagnosis of GI polyposis and cancer in a large JP kindred.
Methods:
Medical records were reviewed, patients were interviewed, and histories were taken. Pathology reports and slides were reviewed by our pathologists. A database was created for analysis of clinical and pathologic factors.
Results:
This kindred contains 117 members, 29 of whom have had upper or lower GI polyps or cancer, or both. All those affected have had colonic juvenile polyps or cancer, except for two who died of advanced gastric cancer and never had colonic evaluation. Nine individuals have had both upper and lower GI polyps or cancer. Sixteen of 29 (55%) affected patients have developed gastrointestinal cancer. Eleven (38%) have had colon cancer, and six (21%) have had upper GI cancers.
Conclusions:
The risk of gastrointestinal malignancy in affected members of this JP kindred exceeds 50%. The high risk of GI cancer warrants frequent endoscopic screening of both affected and at-risk family members. Screening will soon be facilitated by presymptomatic genetic testing for the identification of gene carriers.
More Related Videos
06:21Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Ulcerative Colitis
Diverticular Disease of the Colon